Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,283.04
(
-0.98%
)
News Focus
News Focus
Post# of 7747
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Ecomike

Send PM Follow Ignore
Followers 744
Posts 63587
Boards Moderated 9
Alias Born 10/05/2009

Ecomike

Re: surf1944 post# 1223

Monday, 03/25/2013 11:57:10 PM

Monday, March 25, 2013 11:57:10 PM

Post# of 7747
Today's news is note worthy since CYTR sold the drug rights to ANX which recently changed its name to MSTX, and they just won European orphan drug status. CYTR gets royalties and MSTX shares for reaching certain goals!!!! Need to go back about 12 months to the 8-Ks to get the details. MSTX has made this their lead drug!! ANX-188 IIRC is the name of the drug. Correction it is now MST-188!!!

http://ih.advfn.com/p.php?pid=nmona&article=56888400&symbol=MSTX

Ambition with out knowledge is like ship in dry dock. Going nowhere fast!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today